Ventrus Biosciences, Inc. (Nasdaq: VTUS) has entered into a merger agreement with Assembly Pharmaceuticals, a privately held biopharmaceutical company, in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE